Publications

PHYSICAL FUNCTION IMPAIRMENT AND FRAILTY IN MIDDLE-AGED PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS IN THE REPRIEVE TRIAL ANCILLARY STUDY PREPARE

The Journal of Infectious Diseases, July 2020.

Jul 09, 2020

ASSOCIATION OF MALE SEX AND OBESITY WITH RESIDUAL PLASMA HUMAN IMMUNODEFICIENCY VIRUS 1 VIREMIA IN PERSONS ON LONG-TERM ANTIRETROVIRAL THERAPY

The Journal of Infectious Diseases, June 2020.

Jun 30, 2020

BRIEF REPORT: SEX DIFFERENCES IN OUTCOMES FOR INDIVIDUALS PRESENTING FOR THIRD-LINE ANTIRETROVIRAL THERAPY

JAIDS, June 2020.

Jun 01, 2020

BRIEF REPORT: SEX DIFFERENCES IN OUTCOMES FOR INDIVIDUALS PRESENTING FOR THIRD-LINE ANTIRETROVIRAL THERAPY

JAIDS, June 2020.

Jun 01, 2020

TREATMENT OF ADVANCED AIDS-ASSOCIATED KAPOSI SARCOMA IN RESOURCE-LIMITED SETTINGS: A THREE-ARM, OPEN-LABEL, RANDOMISED, NON-INFERIORITY TRIAL

The Lancet, April 2020.

Apr 11, 2020

PARTICIPANT PERSPECTIVES IN AN HIV CURE-RELATED TRIAL CONDUCTED EXCLUSIVELY IN WOMEN IN THE UNITED STATES: RESULTS FROM AIDS CLINICAL TRIALS GROUP 5366

AIDS Research and Infectious Diseases, April 2020 Led by Dr.

Apr 09, 2020

PRIOR CASE OF RESISTANCE ON DOLUTEGRAVIR PLUS LAMIVUDINE DUAL THERAPY

AIDS Research and Human Retroviruses, April 2020 The last few years have witnessed increased interest in treating HIV with two instead of three active drugs.

Apr 09, 2020

INTRAHEPATIC VIRAL KINETICS DURING DIRECT-ACTING ANTIVIRALS FOR HEPATITIS C IN HUMAN IMMUNODEFICIENCY VIRUS COINFECTION: THE AIDS CLINICAL TRIALS GROUP A5335S SUBSTUDY

The Journal of Infectious Diseases, March 2020 Direct-acting antivirals (DAAs) targeting hepatitis C virus (HCV) have revolutionized outcomes in HIV coinfection.

Mar 23, 2020

TREATMENT OF ADVANCED AIDS-ASSOCIATED KAPOSI SARCOMA IN RESOURCE-LIMITED SETTINGS: A THREE-ARM, OPEN-LABEL, RANDOMISED, NON-INFERIORITY TRIAL

The Lancet, March 2020 Dr.

Mar 05, 2020

ANTIRETROVIRAL THERAPY INITIATION IS ASSOCIATED WITH DECREASED VISCERAL AND SUBCUTANEOUS ADIPOSE TISSUE DENSITY IN PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS

Clinical Infectious Diseases, February 2020 Disturbances in adipose tissue (AT), also known by the general public as “fat,” in people living with HIV include lipodystrophy (fat loss or gain) and obesity.

Feb 28, 2020

RISK FACTORS FOR WEIGHT GAIN FOLLOWING SWITCH TO INTEGRASE INHIBITOR–BASED ANTIRETROVIRAL THERAPY

Clinical Infectious Diseases, February 2020 Research suggests that integrase strand transfer inhibitors (INSTIs) are associated with greater weight gain compared to other HIV medications.

Feb 26, 2020

BASELINE 10-YEAR CARDIOVASCULAR RISK SCORES PREDICT COGNITIVE FUNCTION IN OLDER PERSONS, AND PARTICULARLY WOMEN, LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION

Clinical Infectious Diseases, January 2020 Memory problems, difficulty concentrating, and inability to multi-task, among other cognitive issues, are common complaints of people living and aging with HIV.

Jan 03, 2020